Valneva SE (VLA)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

€3.754

Buy

€3.764

arrow-up€0.028 (+0.75%)

Prices updated at 15 Dec 2025, 09:44 CET

Prices minimum 15 mins delay

Prices in EUR

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes two vaccines for travelers; one for the prevention of Japanese encephalitis (IXIARO) and the second (DUKORAL) for the prevention of cholera and diarrhoea.

FTSE EuroFirst 300

0.64%

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	€3.76 - €3.68
	€5.42 - €1.73
	-
	644.39m
	-
	-
	178,715
	4.28
	1,291,737.76
	1.32
	162.52m
	FR0004056851
	-0.65
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.